Cargando…
POS-950 COVID-19 IN END STAGE KIDNEY DISEASE WITH RENAL REPLACEMENT THERAPIES: OUR EXPERIENCE IN PENANG
Autores principales: | LEE, S.Y., Ong, Y.C., Liew, Y.F., Ong, L.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854808/ http://dx.doi.org/10.1016/j.ekir.2022.01.990 |
Ejemplares similares
-
POS-977 RISK OF COVID-19 INFECTION POST VACCINATION PROGRAMME IN PATIENTS WITH END STAGE KIDNEY DISEASE IN PENANG STATE
por: YU CHEN, O., et al.
Publicado: (2022) -
POS-967 PUBLIC-PRIVATE PARTNERSHIP TO PROVIDE HAEMODIALYSIS IN COVID-19 END-STAGE KIDNEY DISEASE PATIENTS IN KLANG VALLEY, MALAYSIA
por: TAN, M.H., et al.
Publicado: (2022) -
Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease
por: Østergaard, Jakob A., et al.
Publicado: (2022) -
Quality of Life among Patients Undergoing Hemodialysis in Penang, Malaysia
por: Ramatillah, Diana Laila, et al.
Publicado: (2017) -
POS-817 COVID-19 INFECTION AND VACCINATION IN KIDNEY TRANSPLANT RECIPIENTS
por: TAY, L.L., et al.
Publicado: (2022)